Search Results
Found 1 results
510(k) Data Aggregation
(127 days)
The Access BR Monitor assay is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of CA 15-3 antigen levels in human serum and plasma using the Access Immunoassay Systems. This device is indicated for use in the measurement of CA 15-3 antigen to aid in the management of breast cancer patients. Serial testing for patient CA 15-3 antigen concentrations should be used in conjunction with other clinical methods for monitoring breast cancer.
The Access BR Monitor reagents, calibrators, and the Access Immunoassay Analyzers (Access, Access 2, Synchron LXi 725, and UniCel Dxl 800) comprise the Access Immunoassay Systems for the quantitative determination of CA 15-3 antigen in human serum and plasma.
Here's a breakdown of the acceptance criteria and study information for the Beckman Coulter Access BR Monitor, based on the provided document:
Acceptance Criteria and Device Performance
Acceptance Criteria Category | Specific Criteria/Metric | Reported Device Performance/Result |
---|---|---|
Imprecision (Analytical) | Within-run imprecision (CV) | Ranged from 1.4% CV to 2.2% CV for concentrations from ~15 to 662 U/mL. |
Between-run imprecision (CV) | Ranged from 1.6% CV to 4.1% CV. | |
Total imprecision (CV) | Ranged from 2.1% CV to 4.6% CV. | |
Analytical Sensitivity | Lowest detectable level of CA 15-3 antigen |
Ask a specific question about this device
Page 1 of 1